Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-09-002702
Filing Date
2009-05-14
Accepted
2009-05-14 16:21:49
Documents
1
Period of Report
2009-05-12

Document Format Files

Seq Description Document Type Size
1 c57643_ex.html 4  
1 c57643_ex.xml 4 6934
  Complete submission text file 0000930413-09-002702.txt   9096
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ENZON PHARMACEUTICALS INC. RTE 202/206 BRIDGEWATER NJ 08807
Business Address
del Campo Ralph (Reporting) CIK: 0001323683 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 09826950